{"data":[{"accessionNo":"0001373604-26-000057","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2026-09-30","reportingPerson":"Braden M Leonard","reportingCik":null,"personType":"IN","sharesOwned":4264400,"percentOfClass":6.77,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001373604-26-000057","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2026-09-30","reportingPerson":"BML Investment Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3864400,"percentOfClass":6.1,"filedAt":"2026-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-352971","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2026-06-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":4338534,"percentOfClass":6.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-352971","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2026-06-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":4338534,"percentOfClass":6.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001913491-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary shares, par value $0.000174","eventDate":"2026-06-30","reportingPerson":"Wei Zheng","reportingCik":null,"personType":"IN","sharesOwned":2520359,"percentOfClass":4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001913491-26-000003","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary shares, par value $0.000174","eventDate":"2026-03-31","reportingPerson":"Wei Zheng","reportingCik":null,"personType":"IN","sharesOwned":3876036,"percentOfClass":6.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001912836-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary Shares, par value $0.000174 per share","eventDate":"2026-04-14","reportingPerson":"Wubin Pan","reportingCik":null,"personType":"IN","sharesOwned":6026813,"percentOfClass":9.6,"filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001912836-26-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":"207523101","securityClass":"Ordinary Shares, par value $0.000174 per share","eventDate":"2026-04-14","reportingPerson":"BioFortune Inc","reportingCik":null,"personType":"CO","sharesOwned":5987431,"percentOfClass":9.5,"filedAt":"2026-04-14","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-138013","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"James Huang","reportingCik":"0001573160","personType":"IN","sharesOwned":13160000,"percentOfClass":21.2,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-138013","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"Panacea Innovation Limited","reportingCik":"0002010692","personType":"CO","sharesOwned":13160000,"percentOfClass":21.2,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-138013","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"Panacea Venture Healthcare Fund II, L.P.","reportingCik":"0001869939","personType":"PN","sharesOwned":13160000,"percentOfClass":21.2,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-138013","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":"G23549101","securityClass":"Ordinary Shares","eventDate":"2026-03-31","reportingPerson":"Panacea Venture Healthcare Fund II GP Company, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":13160000,"percentOfClass":21.2,"filedAt":"2026-04-01","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-055654","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174 per share","eventDate":"2025-12-31","reportingPerson":"Wubin Pan","reportingCik":null,"personType":"IN","sharesOwned":6026813,"percentOfClass":10.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-055654","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174 per share","eventDate":"2025-12-31","reportingPerson":"BioFortune Inc.","reportingCik":null,"personType":"CO","sharesOwned":5987431,"percentOfClass":10.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-055603","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174 per share","eventDate":"2025-12-31","reportingPerson":"Zheng Wei","reportingCik":null,"personType":"IN","sharesOwned":5015960,"percentOfClass":9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-055136","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2025-12-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":4933086,"percentOfClass":8.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-26-055136","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174 per Share","eventDate":"2025-12-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":4933086,"percentOfClass":8.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001913491-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Ltd","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares, par value $0.000174","eventDate":"2025-11-26","reportingPerson":"Wei Zheng","reportingCik":null,"personType":"IN","sharesOwned":5527528,"percentOfClass":9.9,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-25-300640","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2025-11-24","reportingPerson":"Panacea Innovation Limited","reportingCik":"0002010692","personType":"CO","sharesOwned":12000000,"percentOfClass":21.5,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-25-300640","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2025-11-24","reportingPerson":"Panacea Venture Healthcare Fund II, L.P.","reportingCik":"0001869939","personType":"PN","sharesOwned":12000000,"percentOfClass":21.5,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-25-300640","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2025-11-24","reportingPerson":"Panacea Venture Healthcare Fund II GP Company, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":12000000,"percentOfClass":21.5,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"},{"accessionNo":"0001193125-25-300640","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001835268","issuerName":"Connect Biopharma Holdings Limited","ticker":"CNTB","cusip":null,"securityClass":"Ordinary Shares","eventDate":"2025-11-24","reportingPerson":"James Huang","reportingCik":"0001573160","personType":"IN","sharesOwned":12000000,"percentOfClass":21.5,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/cntb"}],"updatedAt":"2026-11-03T19:38:18.103Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cntb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}